期刊文献+

多发性骨髓瘤骨髓活检切片与涂片的比较 被引量:4

Comparison of Bone Marrow Biopsy and Smear Efficacy in Patients with Multiple Myeloma
下载PDF
导出
摘要 本研究探讨骨髓活检在多发性骨髓瘤诊断中的意义。观察279例多发性骨髓瘤患者的骨髓涂片及骨髓活检切片,就骨髓增生程度,骨髓中浆细胞浸润度及增殖模式,骨髓间质病理变化及骨髓纤维化程度进行比较。结果表明:骨髓活检切片显示的增生程度明显高于骨髓涂片;骨髓切片的浆细胞增殖模式与骨髓涂片的浆细胞比例不完全一致;骨髓纤维化程度对骨髓涂片和活检的细胞增生度一致性有影响。结论:骨髓活检切片比骨髓涂片能更准确地反映骨髓增生程度、浆细胞浸润情况及增殖模式,对多发性骨髓瘤的诊断具有重要价值。 This study was aimed to explore the significance of the bone marrow biopsy for the diagnosis of multiple myeloma. Bone marrow smears and bone marrow biopsy originated from 279 cases of multiple myeloma were detected and compared in term of bone marrow hyperplasia, bone marrow plasma cell infiltration, proliferation mode, pathological changes in the bone marrow stroma and myelofibrosis. The results indicated that the levels of proliferation in bone marrow biopsy was significantly higher than that in bone marrow smears. Plasma cell proliferation mode in bone marrow biopsy was not completely consistent with the proportion of plasma cells in bone marrow smears. The myelofibrosis level displayed influence on the consistency of the proliferation between bone marrow smears and biopsies. It is concluded that as compared with bone marrow smears the bone marrow biopsy can more accurately reflect the levels of bone marrow hyperplasia and bone marrow plasma cell infiltration, proliferation mode and so on. Bone marrow biopsy is valuable for multiple myeloma diagnosis.
出处 《中国实验血液学杂志》 CAS CSCD 北大核心 2012年第6期1389-1391,共3页 Journal of Experimental Hematology
关键词 多发性骨髓瘤 骨髓涂片 骨髓活检 multiple myeloma bone marrow smear bone marrow biopsy
  • 相关文献

参考文献2

二级参考文献2

共引文献2

同被引文献23

  • 1孙峰,刘红,陈秀芳,曹海峰,尹红.骨髓活检在多发性骨髓瘤诊断及鉴别诊断中的价值[J].南通大学学报(医学版),2008,28(2):106-107. 被引量:9
  • 2赵应斌,吕桂桦,丁燕玲,刘纲毅,黎华莲.多发性骨髓瘤细胞形态学分型分析[J].现代检验医学杂志,2006,21(1):57-58. 被引量:4
  • 3蒲权,杨梅如.血液病骨髓诊断病理学[M].北京:科学出版社,2002.103. 被引量:2
  • 4蒲权.实用血液病理学[M].北京:科学出版社,2013:62,494-495. 被引量:1
  • 5Ludwig H, Durie BG, Bolejack V, et al. Myeloma in patients younger than age 50 years presents with more favorable features and shows better survival:an analysis of 10 549 patients form the International My- eloma Working Group[J]. Blood, 2008,111 (8) .- 4039- 4047. 被引量:1
  • 6Terpstra WE, Lokhorst HM, Blomjous F, et al. Com- parison of plasma cell infiltration in bone marrow bi opsies and aspirates in patient with multiple myeloma [J]. Br J Haematol,1992:82(1) :46 49. 被引量:1
  • 7Basak GW, Srivastava AS, Malhotra R, et al. Multiple myeloma bone marrow niehe[J]. Curr Pharm Bioteeh- nol, 2009,10 (3) : 345-346. 被引量:1
  • 8Stifter S,Babarovic E, Valkovic T, et al. Combined e- valuation of bone marrow aspirate and biopsy is supe- rior in the prognosis of multiple myeloma[J]. Diagn Pathol, 2010 (5): 30. 被引量:1
  • 9Yuji Nishiyama,Ukihide Tateishi,Kazuya Shizukuishi,Ayako Shishikura,Etsuko Yamazaki,Hiroto Shibata,Tomohiro Yoneyama,Yoshiaki Ishigatsubo,Tomio Inoue.Role of 18 F-fluoride PET/CT in the assessment of multiple myeloma: initial experience[J]. Annals of Nuclear Medicine . 2013 (1) 被引量:1
  • 10P. Spinnato,A. Bazzocchi,A. Brioli,C. Nanni,E. Zamagni,U. Albisinni,M. Cavo,S. Fanti,G. Battista,E. Salizzoni.Contrast enhanced MRI and 18 F-FDG PET-CT in the assessment of multiple myeloma: A comparison of results in different phases of the disease[J]. European Journal of Radiology . 2012 (12) 被引量:1

引证文献4

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部